Research Article
Real-World Experience with AGA Guidelines in the Management of Crohn’s Disease following Ileocolonic Resection: A Retrospective Cohort Study
Table 1
Demographic and clinical characteristics of CD patients.
| | Characteristics | (%)/IQR |
| | Gender (male) | 70 (68.3) | | Age at diagnosis (years) | 25 (20-31) | | Age at surgery (years) | 29 (24-35) | | Disease duration (months) | 48 (12-72) | | Perianal disease (yes) | 37 (36.6) | | Active smokers (yes) | 13 (12.9) | | Disease behavior (Montreal classification) | | | B1 nonstricturing, nonpenetrating | 18 (17.8) | | B2 stricturing | 48 (47.5) | | B3 penetrating | 35 (34.7) | | Medication before surgery | | | 5-ASA | 45 (44.5) | | Immunomodulator | 42 (41.6) | | Steroids | 31 (30.7) | | Infliximab | 24 (23.8) | | Appendix resection history | 18 (17.8) | | Prior surgery related to CD | 15 (14.8) | | Prophylactic medication after index surgery | | | Only antibiotics | 30 (29.7) | | Thiopurines | 42 (41.6) | | Infliximab | 14 (13.9) | | Thiopurines+infliximab | 15 (14.8) | | Postoperative complication (yes) | 12 (11.9) | | Mean follow-up time (m) | 7 (6-12) | | Postoperative endoscopic recurrence | 29 (28.7) |
|
|
